Evidence map›Paper›PMID 27118948›Full record

ArticleGastroenterology & hepatology2015

Diet and Inflammatory Bowel Disease.

Karina Knight-Sepulveda, Susan Kais, Rebeca Santaolalla, Maria T Abreu

Registry-linked trialAbstract read
PubMed Full text at PMC
In one paragraph

Article in Gastroenterology & hepatology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04882566 (Assessment of Nutritional Knowledge in Patients With Inflammatory Bowel Disease), which is not on this map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04882566 unknown statusnot on this mapstarted 2021, after this paper: background citation

Assessment of Nutritional Knowledge in Patients With Inflammatory Bowel Disease

TypeobservationalSponsorAssiut UniversityRan2021 to 2022Enrolled100ConditionsUlcerative Colitis, Crohn Disease, NutritionArmsPaleolithic Diet
3 · Its place in the literature

Who cites it

61 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. iMetaOmics · 2025
    Review
  8. Review
  9. Article
  10. Article
  11. The emerging role of hypoxia and environmental factors in inflammatory bowel disease.Toxicological sciences : an official journal of the Society of Toxicology · 2024
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Observational

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Karina Knight-SepulvedaMs Knight-Sepulveda is a clinical dietitian and Dr Kais is an IBD clinical fellow at the UHealth Crohn's and Colitis Center in the University of Miami Health System in Miami, Florida. Dr Santaolalla is the research laboratory manager at The Micky & Madeleine Arison Family Foundation Crohn's & Colitis Discovery Laboratory at the University of Miami Miller School of Medicine in Miami, Florida. Dr Abreu is a professor of medicine, professor of microbiology and immunology, chief of the Division of Gastroenterology, director of the UHealth Crohn's and Colitis Center, and principal investigator at The Micky & Madeleine Arison Family Foundation Crohn's & Colitis Discovery Laboratory at the University of Miami Miller School of Medicine.
Susan KaisMs Knight-Sepulveda is a clinical dietitian and Dr Kais is an IBD clinical fellow at the UHealth Crohn's and Colitis Center in the University of Miami Health System in Miami, Florida. Dr Santaolalla is the research laboratory manager at The Micky & Madeleine Arison Family Foundation Crohn's & Colitis Discovery Laboratory at the University of Miami Miller School of Medicine in Miami, Florida. Dr Abreu is a professor of medicine, professor of microbiology and immunology, chief of the Division of Gastroenterology, director of the UHealth Crohn's and Colitis Center, and principal investigator at The Micky & Madeleine Arison Family Foundation Crohn's & Colitis Discovery Laboratory at the University of Miami Miller School of Medicine.
Rebeca SantaolallaMs Knight-Sepulveda is a clinical dietitian and Dr Kais is an IBD clinical fellow at the UHealth Crohn's and Colitis Center in the University of Miami Health System in Miami, Florida. Dr Santaolalla is the research laboratory manager at The Micky & Madeleine Arison Family Foundation Crohn's & Colitis Discovery Laboratory at the University of Miami Miller School of Medicine in Miami, Florida. Dr Abreu is a professor of medicine, professor of microbiology and immunology, chief of the Division of Gastroenterology, director of the UHealth Crohn's and Colitis Center, and principal investigator at The Micky & Madeleine Arison Family Foundation Crohn's & Colitis Discovery Laboratory at the University of Miami Miller School of Medicine.
Maria T AbreuMs Knight-Sepulveda is a clinical dietitian and Dr Kais is an IBD clinical fellow at the UHealth Crohn's and Colitis Center in the University of Miami Health System in Miami, Florida. Dr Santaolalla is the research laboratory manager at The Micky & Madeleine Arison Family Foundation Crohn's & Colitis Discovery Laboratory at the University of Miami Miller School of Medicine in Miami, Florida. Dr Abreu is a professor of medicine, professor of microbiology and immunology, chief of the Division of Gastroenterology, director of the UHealth Crohn's and Colitis Center, and principal investigator at The Micky & Madeleine Arison Family Foundation Crohn's & Colitis Discovery Laboratory at the University of Miami Miller School of Medicine.

Funding

Role of TLR4 in Colitis Associated NeoplasiaR01DK099076 · NIDDK · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Maria Teresa Abreu · 2014 to 2026
$4.7M
NIDDK NIH HHS R01 DK099076
6 · The paper itself

Abstract

Patients with inflammatory bowel disease (IBD) are increasingly becoming interested in nonpharmacologic approaches to managing their disease. One of the most frequently asked questions of IBD patients is what they should eat. The role of diet has become very important in the prevention and treatment of IBD. Although there is a general lack of rigorous scientific evidence that demonstrates which diet is best for certain patients, several diets-such as the low-fermentable oligosaccharide, disaccharide, monosaccharide, and polyol diet; the specific carbohydrate diet; the anti-inflammatory diet; and the Paleolithic diet-have become popular. This article discusses the diets commonly recommended to IBD patients and reviews the supporting data.

Indexed as

anti-inflammatory diethigh-fat dietinflammatory bowel diseaselow-fat dietLow-FODMAP dietPaleolithic dietspecific carbohydrate diet

Identifiers

PMID27118948
PMCPMC4843040

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.